Alfredo Trento, MD

Vice Chair of Outreach & Business Development, Cardiac Surgery

Director Emeritus, Cardiothoracic Surgery

Professor, Surgery

Alfredo Trento, MD

Cardiac Surgery
127 S San Vicente Blvd #A3600
Los AngelesCA
90048

Phone:

310-423-3851

Fax:

310-423-0246

Alfredo Trento, MD

Vice Chair of Outreach & Business Development, Cardiac Surgery

Director Emeritus, Cardiothoracic Surgery

Professor, Surgery

  • Surgery-Cardio-Thoracic

Aortic Aneurysms

Aortic Valve Surgery / Surgeries

Bicuspid Aortic Valve Disease

Congenital Heart Diseases

Coronary Artery Bypass Surgery / Surgeries (CABG)

Heart Transplants

Heart Valve Surgery / Surgeries

Lung Transplants

Marfan's Syndrome

Mitral Valve Surgery / Surgeries

Robotic Cardiac Surgery / Surgeries

Ross Procedure

The research of Alfredo Trento, MD, focuses on several areas: heart and heart-lung transplantation procedures, graft atherosclerosis (and ways to prevent it by creating an animal model of heart transplantation and using different immunosuppressant agents) and the process of calcification and degeneration of valve bioprosthesis.

  • Estelle, Abe, and Marjorie Sanders Chair in Cardiac Surgery, 2002
  • American Association for Thoracic Surgery, 1997
  • International Society of Heart Failure, 1995
  • Western Thoracic Surgical Association, 1994
  • The Society of Thoracic Surgeons, 1991
  • Goland S, Czer LS, De Robertis MA, Mirocha J, Kass RM, Fontana GP, Chang W, Trento A. Risk factors associated with reoperation and mortality in 252 patients after aortic valve replacement for congenitally bicuspid aortic valve disease. Ann Thorac Surg. 2007;83(3):931-937.
  • Goland S, Czer LS, Kass RM, De Robertis MA, Mirocha J, Coleman B, Capelli C, Raissi S, Cheng W, Fontana G, Trento A. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.J Heart Lung Transplant. 2007;26(4):312-318.
  • Goland S, Czer LS, Kass RM, Siegel RJ, Mirocha J, De Robertis MA, Lee J, Raissi S, Cheng W, Fontana G, Trento A. Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool. J Am Coll Cardiol. 2008;51(12):1214-1220.

English / Italian

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.